CODXCo-Diagnostics Inc
$1.96
$0.145
(6.91%)
EarningsAug 14
Mkt Cap$11.09M
Vol134,136.00
Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform
Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform PR Newswire SALT LAKE CITY, July 22, 2026 PCR Pro Instruments and MTB Test Kits...
PR Newswire
EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin
Co-Diagnostics' India joint venture CoSara has started clinical studies for its rapid TB PCR test, advancing deployment of its point-of-care platform.read more...
Benzinga
Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer
Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer PR Newswire SALT LAKE CITY, July 16, 2026 SALT LAKE CITY, July 16, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX)("Co-Dx" or "the Company...
PR Newswire
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand PR Newswire SALT LAKE CITY, July 8, 2026 Invited by the Stop TB Partnership and the Global Fund...
PR Newswire
Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test
Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test PR Newswire SALT LAKE...
PR Newswire
EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform
Co-Diagnostics completed clinical and analytical studies for its PCR Flu A/B & RSV test and plans FDA 510(k) and CLIA waiver submissions.read more...
Benzinga
Co-Diagnostics Vector Smart Division Expands Footprint to 21 States
Co-Diagnostics Vector Smart Division Expands Footprint to 21 States Co-Diagnostics Vector Smart Division Expands Footprint to 21 States PR Newswire SALT LAKE CITY, June 25, 2026 Expansion coincides with Co-Dx webinar for prospective mosquito abatement district customers in honor of National...
PR Newswire
Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line
Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line PR Newswire SALT LAKE CITY, June 18, 2026 Visit has included...
PR Newswire
Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx PCR Pro with Mexico Distributor Agreement
Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx PCR Pro with Mexico Distributor Agreement Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx PCR Pro with Mexico Distributor Agreement PR Newswire SALT LAKE CITY, June 11, 2026 Longstanding...
PR Newswire
<
1
2
...
>
Advertisement|Remove ads.
Latest CODX News
ViewCo-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform
PR Newswire
EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin
Benzinga
Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer
PR Newswire
DIA13
22
QQQ15
40
MSTR2
5Advertisement|Remove ads.